Security key
81728A108
- Security type / class
- Equity / COM
- Total 13F shares
- 2,206,817
- Total 13F value
- $1,319,693
- Share change
- +107,018
- SEC-reported price per share
- $0.60
- Number of holders
- 19
- Value change
- +$63,592
- Number of buys
- 5
- Number of sells
- 9
Report period
Q3 2024
Institutions
19
Top holders
10
SNSE full security history
Ownership snapshot
Full 13F holder table
Faeth Therapeutics, Inc. SEC filings
Faeth Therapeutics, Inc. company facts
Broader feeds
Ownership snapshot
Top reported holders of SNSE - Sensei Biotherapeutics, Inc. - COM (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Ikarian Capital, LLC
Disclosed value leader
Ikarian Capital, LLC
Comparable rows
0/15
Latest evidence
30 Jun 2024
13F
3/4/5
Highest disclosed value: $403,065
15 rows are not safely comparable across share classes.
Showing 1-6 of 15 holder rows.
Quick read
Ikarian Capital, LLC has the largest disclosed position value at $403.1K.
0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Ikarian Capital, LLC's linked filing trail.
Disclosed position value
Top 5
Ikarian Capital, LLC
$403.1K
VANGUARD GROUP INC
$383.7K
RENAISSANCE TECHNOLOGIES LLC
$138.8K
BOOTHBAY FUND MANAGEMENT, LLC
$107.2K
GEODE CAPITAL MANAGEMENT, LLC
$101.2K
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Ikarian Capital, LLC |
13F
Company
|
—
class O/S missing
|
$403,065
650,000 shares
|
— | 30 Jun 2024 |
| VANGUARD GROUP INC |
13F
Company
|
—
class O/S missing
|
$383,691
618,757 shares
|
— | 30 Jun 2024 |
| RENAISSANCE TECHNOLOGIES LLC |
13F
Company
|
—
class O/S missing
|
$138,769
223,785 shares
|
— | 30 Jun 2024 |
| BOOTHBAY FUND MANAGEMENT, LLC |
13F
Company
|
—
class O/S missing
|
$107,175
172,835 shares
|
— | 30 Jun 2024 |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
Company
|
—
class O/S missing
|
$101,180
163,139 shares
|
— | 30 Jun 2024 |
| Robert Hamilton Pierce |
3/4/5
Chief R&D Officer
|
—
class O/S missing
|
$80,294
94,463 shares
|
— | 15 Feb 2022 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
19
Shares
2,206,817
Rows available
19
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q3 2024 vs Q2 2024 Across Filers
Q2 2024 holders
23
Q3 2024 holders
19
Holder diff
-4
| Investor | Q2 2024 Shares | Q3 2024 Shares | Share Diff | Share Chg % | Q2 2024 value | Q3 2024 value | Value change | Value Chg % |
|---|